Effects of adenosine 3′:5′‐monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets
- 15 February 1979
- journal article
- Published by Wiley in FEBS Letters
- Vol. 98 (2), 247-250
- https://doi.org/10.1016/0014-5793(79)80192-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cyclic AMP and platelet prostaglandin synthesisProstaglandins, 1977
- On the Interrelationship of Prostaglandin Endoperoxide G2 and Cyclic Nucleotides in Platelet FunctionEuropean Journal of Biochemistry, 1977
- Cyclic adenosine 3′,5′-monophosphate and prostacyclin inhibit membrane phospholipase activity in plateletsBiochemical and Biophysical Research Communications, 1977
- Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.JCI Insight, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Radioimmunoassay for Thromboxane B2Analytical Letters, 1976
- Metabolism of [14C]arachidonic acid by human plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human plateletsBiochemical and Biophysical Research Communications, 1976
- Cyclic 3′,5′-adenosine monophosphate in human blood plateletsJCI Insight, 1971
- Platelet aggregation I. Regulation by cyclic AMP and prostaglandin E1Biochemical and Biophysical Research Communications, 1969